kirkland signature mucus dm
- Product NDC
- 63981-812
- 11-digit product format
- 639810812
- Labeler code
- 63981
- Product ID
- 63981-812_10b26050-9454-4405-a5d2-b74b8f29f15e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- dextromethorphan HBr, guaifenesin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Costco Wholesale Company
- Application
- ANDA207602
- Marketing category
- ANDA
- Marketing start
- 2023-05-19
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 60; 1200 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | ||
| A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207602-001 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207602-002 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-03-05 | a72a2bbeb626… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RUGBY MUCUS RELIEF DM ER | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rugby Laboratories | 8090d561-0478-435d-ad6f-2334e1823bc3 | 2026-07-28 | Warnings | 207602 ANDA207602 |
| Good Sense Mucus DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | L. Perrigo Company | 34f26b33-af34-470a-b57e-921fbdcbd9af | 2026-07-13 | Warnings | 207602 ANDA207602 |
| MUCUS RELIEF DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | db57f6b3-30ca-4a65-9043-f61be24d9b50 | 2026-06-25 | Warnings | 207602 ANDA207602 |
| mucus relief DM MAX | DEXTROMETHORPHAN HBR, GUAIFENESIN | Rite Aid Corporation | a5fd7378-fd7b-400b-a374-0f3bee37702d | 2026-06-03 | Warnings | 207602 ANDA207602 |
| mucus relief DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rite Aid Corporation | 84b5d83d-aea5-42ed-b20c-96d3b389c8c0 | 2026-05-27 | Warnings | 207602 ANDA207602 |
| mucus dm extended release | GUAIFENESIN, DEXTROMETHORPHAN HBR | CVS Pharmacy | 1bc37ee4-df27-4358-b724-6b55406dbce6 | 2026-05-08 | Warnings | 207602 ANDA207602 |
| mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | HyVee Inc | 6bce66d6-e76a-4273-aff9-7ee6adc18980 | 2026-03-18 | Warnings | 207602 ANDA207602 |
| MUCUS DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | HyVee Inc | 4ffa61d9-d24d-4982-a318-1660b56704e6 | 2026-03-02 | Warnings | 207602 ANDA207602 |
| Good Sense Mucus DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Sportpharm LLC | 81fb0ce7-1b13-4b9d-8f98-671ffd9205c3 | 2026-02-23 | Warnings | 207602 ANDA207602 |
| MUCUS RELIEF DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 85ecf5bf-28a1-4b9d-9e99-c9e91ddc85e1 | 2026-02-17 | Warnings | 207602 ANDA207602 |
| RUGBY MUCUS RELIEF DM ER | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | A-S Medication Solutions | 511a5d9b-16a6-481c-a3d3-bcba911ecc9d | 2026-02-11 | Warnings | 207602 ANDA207602 |
| Berkley and Jensen Mucus Relief DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | BJWC | d3b94cce-e6f3-43ec-a927-7b7183744433 | 2025-12-17 | Warnings | 207602 ANDA207602 |
| mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Meijer Distribution Inc | cb2b9828-1665-4b66-a59a-b9f9539b51b5 | 2025-09-17 | Warnings | 207602 ANDA207602 |
| GOOD NEIGHBOR PHARMACY MUCUS DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Amerisource Bergen | f0aea945-1c18-4c6f-a7d1-6d56624011bb | 2025-09-12 | Warnings | 207602 ANDA207602 |
| good neighbor pharmacy mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Amerisource Bergen | f7925a6b-7029-4389-bf1b-8c0f5e79b950 | 2025-09-11 | Warnings | 207602 ANDA207602 |
| kirkland signature mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Costco Wholesale Company | d2151492-c6bb-42c7-887f-37ef3eab3460 | 2025-08-20 | Warnings | 207602 ANDA207602 63981-812 |
| good sense mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | L Perrigo Company | 654dc991-1984-43cc-a00e-0c85d910b323 | 2025-08-20 | Warnings | 207602 ANDA207602 |
| mucus dm extended release | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE | CVS Pharmacy | 6c9540ae-aea1-4717-8dca-60850ebdb1b4 | 2025-08-04 | Warnings | 207602 ANDA207602 |
| Topcare Mucus DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Topco Associates LLC | c12c68c3-c1bf-45dd-a311-fe1005189ec1 | 2025-07-16 | Warnings | 207602 ANDA207602 |
| Exchange Select Mucus DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Army & Air Force Exchange Service | 99a11bea-8cf5-4c5d-95b1-eaedccaf9e7d | 2025-07-03 | Warnings | 207602 ANDA207602 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- kirkland signature mucus dm
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 60 mg/1 |
| GUAIFENESIN | 1200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1099074 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d2151492-c6bb-42c7-887f-37ef3eab3460 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63981-812-01 | kirkland signature mucus dm | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 4 | |
| 63981-812-01 | kirkland signature mucus dm | 84 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 84 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63981-812-01 | EA - Each | 63981-812 | a675fb05-a7aa-4dd2-94cb-1481c98f5354 | 1 | 2023-07-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1099074 | guaiFENesin 1200 MG / dextromethorphan HBr 60 MG 12HR Extended Release Oral Tablet | PSN | d2151492-c6bb-42c7-887f-37ef3eab3460 | 4 |
| 1099074 | 12 HR dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG Extended Release Oral Tablet | SCD | d2151492-c6bb-42c7-887f-37ef3eab3460 | 4 |
| 1099074 | dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG 12 HR Extended Release Oral Tablet | SY | d2151492-c6bb-42c7-887f-37ef3eab3460 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63981-812-01 | 63981081201 | 1 BOTTLE in 1 CARTON (63981-812-01) / 84 TABLET, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2023-05-19 | No | No | Current |